Weight loss medications have been available for the past couple of years, but there's been one deterrent: the needle. For those looking for a solution without the jab, Eli Lilly has developed a weight loss pill. According to recent trials, Orforglipron could be just as effective as Ozempic and Mounjaro at lowering blood sugar and aiding weight loss in people with Type 2 diabetes. Trial participants who received the highest dose lost up to 16 pounds in 40 weeks. Eli Lilly is currently seeking FDA approval for the drug, which could be available later this year or in 2026. (newser)
Lifestyle Extras
